Mulberroside A possesses potent uricosuric and nephroprotective effects in hyperuricemic mice

Planta Medica

Volumn 77, Issue 8, 2011, Pages 786-794

  Wang, Cai Ping ^a   Wang, Yemin ^a,b   Wang, Xing ^a   Zhang, Xian ^a   Ye, Jian Feng ^c   Hu, Lin Shui ^d   Kong, Ling Dong ^a  

^a NANJING UNIVERSITY   (China)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Zhejiang Institute of Traditional Chinese Medicine and Natural Drug   (China)

^d Zhejiang CONBA Pharmaceutical Co Ltd   (China)

Author keywords

hyperuricemia; Moraceae; Morus alba L.; mulberroside A; nephroprotective; organic anion transporters; organic cation carnitine transporters; uricosuric

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; BETA N ACETYLGALACTOSAMINIDASE; CREATININE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 9; MEMBRANE PROTEIN; MESSENGER RNA; MULBERROSIDE A; NITROGEN; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; ORGANIC ANION TRANSPORTER 1; ORGANIC CATION TRANSPORTER; OTERACIL; PROBENECID; PROTEIN OCTN1; PROTEIN OCTN2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; URATE; URATE TRANSPORTER 1; UREA; URIC ACID; URICOSURIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOWN REGULATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; HYPERURICEMIA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

ACETYLGLUCOSAMINIDASE; ALBUMINURIA; ANIMALS; BETA 2-MICROGLOBULIN; BLOOD UREA NITROGEN; CARRIER PROTEINS; CREATININE; DISACCHARIDES; DRUGS, CHINESE HERBAL; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HYPERURICEMIA; KIDNEY; KIDNEY DISEASES; MALE; MEMBRANE PROTEINS; MICE; MORUS; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS; PROTECTIVE AGENTS; STILBENES; URIC ACID; URICOSURIC AGENTS;

MORACEAE; MORUS ALBA; MUS;

EID: 79957460481     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250599     Document Type: Article

References (41)

1. Choi H K., Mount D B., Reginato A M. Pathogenesis of gout. Ann Intern Med 2005 143 499-516 (Pubitemid 41379398)
2. Weiner D E., Tighiouart H, Elsayed E F., Griffith J L., Salem D N., Levey A S. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008 19 1204-1211
3. Imaoka T, Kusuhara H, Adachi-Akahane S, Hasegawa M, Morita N, Endou H, Sugiyama Y. The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules. J Am Soc Nephrol 2004 15 2012-2022 (Pubitemid 39031340)
4. Caulfield M J., Munroe P B., O'Neill D, Witkowska K, Charchar F J., Doblado M, Evans S, Eyheramendy S, Onipinla A, Howard P, Shaw-Hawkins S, Dobson R J., Wallace C, Newhouse S J., Brown M, Connell J M., Dominiczak A, Farrall M, Lathrop G M., Samani N J., Kumari M, Marmot M, Brunner E, Chambers J, Elliott P, Kooner J, Laan M, Org E, Veldre G, Viigimaa M, Cappuccio F P., Ji C, Iacone R, Strazzullo P, Moley K H., Cheeseman C. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 2008 5 1509-1523
5. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha S H., Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H. Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature 2002 417 447-452 (Pubitemid 34563537)
6. Ichida K, Hosoyamada M, Kimura H, Takeda M, Utsunomiya Y, Hosoya T, Endou H. Urate transport via human PAH transporter hOAT1 and its gene structure. Kidney Int 2003 63 143-155 (Pubitemid 35463915)
7. Eraly S A., Vallon V, Rieg T, Gangoiti J A., Wikoff W R., Siuzdak G, Barshop B A., Nigam S K. Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics 2008 33 180-192 (Pubitemid 351629526)
8. Grover B, Buckley D, Buckley A R., Cacini W. Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes. J Pharmacol Exp Ther 2004 308 949-956 (Pubitemid 38263970)
9. Ji L, Masuda S, Saito H, Inui K. Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy. Kidney Int 2002 62 514-524 (Pubitemid 34779762)
10. Tokuhiro S, Yamada R, Chang X T., Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003 35 341-348 (Pubitemid 37486917)
11. Glube N, Closs E, Langguth P. OCTN2-mediated carnitine uptake in a newly discovered human proximal tubule cell line (Caki-1). Mol Pharm 2007 4 160-168
12. Harris M D., Siegel L B., Alloway J A. Gout and hyperuricemia. Am Fam Physician 1999 59 925-934 (Pubitemid 29108611)
13. Nunome S, Kondo K, Terabayashi S, Sasaki H, Xiao C, Hao X, Okada M. Studies on the quality of mulberry bark (2). Botanical source and chemical components of mulberry cortex. Nat Med 2000 54 33-37 (Pubitemid 30190940)
14. Habu Y, Yano I, Okuda M, Fukatsu A, Inui K. Restored expression and activity of organic ion transporters rOAT1, rOAT3 and rOCT2 after hyperuricemia in the rat kidney. Biochem Pharmacol 2005 69 993-999 (Pubitemid 40312716)
15. Kang D H., Nakagawa T, Feng L L., Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson R J. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002 13 2888-2897 (Pubitemid 35386908)
16. Hall I H., Scoville J P., Reynolds D J., Simlot R, Duncan P. Substituted cyclic imides as potential antigout agents. Life Sci 1990 46 1923-1927 (Pubitemid 20205064)
17. Hu Q H., Wang C A., Li J M., Zhang D M., Kong L D. Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement. Am J Physiol Renal Physiol 2009 297 F1080-F1091
18. Hu Q H., Jiao R Q., Wang X, Lv Y Z., Kong L D. Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice. J Ethnopharmacol 2010 128 685-692
19. Rizwan A N., Burckhardt G. Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm Res 2007 24 450-470 (Pubitemid 46295167)
20. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001 24 691-697 (Pubitemid 33133783)
21. Chonchol M, Shlipak M G., Katz R, Sarnak M J., Newman A B., Siscovick D S., Kestenbaum B, Carney J K., Fried L F. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 2007 50 239-247 (Pubitemid 47095076)
22. Price R G. Urinalysis to exclude and monitor nephrotoxicity. Clin Chim Acta 2000 297 173-182 (Pubitemid 30332288)
23. Lauwerys R, Bernard A. Preclinical detection of nephrotoxicity - description of the tests and appraisal of their health significance. Toxicol Lett 1989 46 13-29 (Pubitemid 19083998)
24. Matsuo H, Chiba T, Nagamori S, Nakayama A, Domoto H, Phetdee K, Wiriyasermkul P, Kikuchi Y, Oda T, Nishiyama J, Nakamura T, Morimoto Y, Kamakura K, Sakurai Y, Nonoyama S, Kanai Y, Shinomiya N. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet 2008 83 744-751
25. Vitart V, Rudan I, Hayward C, Gray N K., Floyd J, Palmer C N., Knott S A., Kolcic I, Polasek O, Graessler J, Wilson J F., Marinaki A, Riches P L., Shu X, Janicijevic B, Smolej-Narancic N, Gorgoni B, Morgan J, Campbell S, Biloglav Z, Barac-Lauc L, Pericic M, Klaric I M., Zgaga L, Skaric-Juric T, Wild S H., Richardson W A., Hohenstein P, Kimber C H., Tenesa A, Donnelly L A., Fairbanks L D., Aringer M, McKeigue P M., Ralston S H., Morris A D., Rudan P, Hastie N D., Campbell H, Wright A F. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008 40 437-442 (Pubitemid 351450879)
26. Preitner F, Bonny O, Laverriere A, Rotman S, Firsov D, Da Costa A, Metref S, Thorens B. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Proc Natl Acad Sci USA 2009 106 15501-15506
27. Vazquez-Mellado J, Jimenez-Vaca A L., Cuevas-Covarrubias S, Alvarado-Romano V, Pozo-Molina G, Burgos-Vargas R. Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology 2007 46 215-219 (Pubitemid 46189778)
28. Hosoyamada M, Ichida K, Enomoto A, Hosoya T, Endou H. Function and localization of urate transporter 1 in mouse kidney. J Am Soc Nephrol 2004 15 261-268 (Pubitemid 38140766)
29. Nigam S K., Bush K T., Bhatnagar V. Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues. Nat Clin Pract Nephrol 2007 3 443-448 (Pubitemid 47123587)
30. Sakurai Y, Motohashi H, Ueo H, Masuda S, Saito H, Okuda M, Mori N, Matsuura M, Doi T, Fukatsu A, Ogawa O, Inui K. Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases. Pharm Res 2004 21 61-67 (Pubitemid 38122293)
31. Urakami Y, Kimura N, Okuda M, Inui K. Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney. Pharm Res 2004 21 976-981 (Pubitemid 38870147)
32. Brown C D. A., Sayer R, Windass A S., Haslam I S., De Broe M E., D'Haese P C., Verhulst A. Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling. Toxicol Appl Pharmacol 2008 233 428-438
33. Ichida K, Hosoyamada M, Hisatome I, Enomoto A, Hikita M, Endou H, Hosoya T. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004 15 164-173 (Pubitemid 38020708)
34. Siu Y P., Leung K T., Tong M K. H., Kwan T H. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006 47 51-59
35. Zhaxi M C., Chen L X., Li X G., Komatsu K, Yao X S., Qiu F. Three major metabolites of mulberroside A in rat intestinal contents and feces. Planta Med 2010 76 362-364
36. Qiu F, Komatsu K, Saito K, Kawasaki K, Yao X S., Kano Y. Pharmacological properties of traditional medicines. XXII. Pharmacokinetic study of mulberroside A and its metabolites in rat. Biol Pharm Bull 1996 19 1463-1467 (Pubitemid 26403253)
37. Keembiyehetty C, Augustin R, Carayannopoulos M O., Steer S, Manolescu A, Cheeseman C I., Moley K H. Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are up-regulated in diabetes. Mol Endocrinol 2006 20 686-697 (Pubitemid 43291218)
38. Hosoyamada M, Sekine T, Kanai Y, Endou H. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol Renal Physiol 1999 276 F122-F128 (Pubitemid 29061732)
39. Kakehi M, Koyabu N, Nakamura T, Uchiumi T, Kuwano M, Ohtani H, Sawada Y. Functional characterization of mouse cation transporter mOCT2 compared with mOCT1. Biochem Biophys Res Commun 2002 296 644-650
40. Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, Tsuji A. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 1997 419 107-111 (Pubitemid 28011227)
41. Lu K M., Nishimori H, Nakamura Y, Shima K, Kuwajima M. A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse. Biochem Biophys Res Commun 1998 252 590-594 (Pubitemid 28556821)